SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics Monthly Activity About

SEC Company Response from Profound Medical (PROF) — May 15, 2026

Profound Medical Corp.
Date: May 15, 2026 · CIK: 0001628808 · Accession: 0001104659-26-062367

Offering / Registration Process

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-295811

Date
May 15, 2026
Author
Rashed Dewan
Form
CORRESP
Company
Profound Medical Corp.

Letter

Profound Medical Corp.

2400 Skymark Avenue, Unit #6

Mississauga, Ontario L4W 5K5

May 15, 2026

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attention: Conlon Danberg

Re: Profound Medical Corp.

Registration Statement on Form S-3

Filed May 12, 2026

File No.333-295811

Acceleration Request

Ladies and Gentlemen:

In accordance with Rule 461 of the Rules and Regulations promulgated under the Securities Act of 1933, as amended, Profound Medical Corp., a corporation existing under the laws of Ontario, Canada (the "Registrant"), hereby respectfully requests that the Securities and Exchange Commission accelerate the effective date of the above-referenced Registration Statement on Form S-3 to Tuesday, May 19, 2026, at 4:30 p.m., Eastern time, or as soon as thereafter practicable.

The cooperation of the staff in meeting the timetable described above is very much appreciated.

Please contact Jeffrey P. Schultz of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Registrant, at (212) 692-6732 with any questions regarding this request.

Very truly yours,
PROFOUND MEDICAL CORP.

Show Raw Text
CORRESP
 1
 filename1.htm

 Profound
Medical Corp.

 2400 Skymark Avenue, Unit #6

 Mississauga, Ontario L4W 5K5

 May 15, 2026

 VIA EDGAR

 U.S. Securities and Exchange Commission

 Division of Corporation Finance

 100 F Street, N.E.

 Washington, D.C. 20549

 Attention: Conlon Danberg

 Re:
 Profound Medical Corp.

 Registration Statement on Form S-3

 Filed May 12, 2026

 File No.333-295811

 Acceleration Request

 Ladies and Gentlemen:

 In accordance with Rule 461 of the Rules
and Regulations promulgated under the Securities Act of 1933, as amended, Profound Medical Corp., a corporation existing under the laws
of Ontario, Canada (the "Registrant"), hereby respectfully requests that the Securities and Exchange Commission accelerate
the effective date of the above-referenced Registration Statement on Form S-3 to Tuesday, May 19, 2026, at 4:30 p.m., Eastern time, or
as soon as thereafter practicable.

 The cooperation of the staff in meeting the timetable
described above is very much appreciated.

 Please contact Jeffrey P. Schultz of Mintz, Levin, Cohn, Ferris, Glovsky
and Popeo, P.C., counsel to the Registrant, at (212) 692-6732 with any questions regarding this request.

 Very truly yours,

 PROFOUND MEDICAL CORP.

 /s/ Rashed Dewan

 Rashed Dewan

 Chief Financial Officer

 cc:
 Mintz, Levin, Cohn, Ferris,
 Glovsky and Popeo, P.C.

 Jeffrey P. Schultz

 Cheryl V. Reicin

 Eric Foster